Endocrinology and Nutrition Service, Hospital Carlos Haya, Málaga (REDIMET Red de Centros de Metabolismo y Nutrición of Instituto de Salud Carlos III), Spain.
Clin Endocrinol (Oxf). 2008 Jan;68(1):102-7. doi: 10.1111/j.1365-2265.2007.03006.x. Epub 2007 Aug 28.
Numerous genes have been associated with the risk for type 2 diabetes mellitus (DM2). In an attempt to understand how specific variants of different genes interact and intervene in the molecular and physiological mechanisms of disorders such as diabetes or insulin resistance, the search for gene-gene interactions is constantly growing. We searched for a possible interaction between two polymorphisms (Trp64Arg of ADRB3 gene and -75G/A of APOA1gene) and the risk for DM2 in a population from southern Spain.
A cross-sectional study in southern Spain of 1020 people, aged 18-65 years. All persons underwent a clinical, anthropometrical and biochemical evaluation, including an oral glucose tolerance test (OGTT). Insulin resistance was measured by homeostasis model of assessment (HOMA). The polymorphisms -75G/A of APOA1 and Trp64Arg of ADRB3 were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and real-time PCR, respectively.
The genotype frequencies of the -75G/A polymorphism of the APOA1 gene were 62.7% GG, 25.7% GA and 11.6% AA, whereas for the Trp64Arg polymorphism of the ADRB3 gene, they were 87.5% Trp/Trp, 11.7% Trp/Arg and 0.8% Arg/Arg. Subjects with both gene variants had a greater odds ratio (OR) of having DM2 [OR = 5.5; 95% confidence interval (CI) = 1.2-23.5] than persons with one or none of the variants, after adjusting for age, sex, body mass index (BMI) and homeostasis model assessment of insulin resistance (HOMA-IR).
Joint association of allele -75A (APOA1) and allele Arg64 (ADRB3) increase the risk of DM2 in a population from southern Spain.
许多基因与 2 型糖尿病(DM2)的风险相关。为了了解不同基因的特定变体如何相互作用并干预糖尿病或胰岛素抵抗等疾病的分子和生理机制,对基因-基因相互作用的研究一直在不断增加。我们在西班牙南部的人群中寻找了 ADRB3 基因的 Trp64Arg 多态性和 APOA1 基因的-75G/A 多态性之间可能存在的相互作用与 DM2 的风险。
在西班牙南部进行了一项横断面研究,共纳入 1020 名年龄在 18-65 岁的人群。所有参与者均接受了临床、人体测量学和生化评估,包括口服葡萄糖耐量试验(OGTT)。胰岛素抵抗用稳态模型评估(HOMA)进行测量。APOA1 基因的-75G/A 多态性和 ADRB3 基因的 Trp64Arg 多态性分别通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)和实时 PCR 检测。
APOA1 基因-75G/A 多态性的基因型频率分别为 62.7% GG、25.7% GA 和 11.6% AA,而 ADRB3 基因的 Trp64Arg 多态性的基因型频率分别为 87.5% Trp/Trp、11.7% Trp/Arg 和 0.8% Arg/Arg。与仅有一种或两种基因变异的个体相比,同时具有两种基因变异的个体患 DM2 的优势比(OR)更高[OR=5.5;95%置信区间(CI)=1.2-23.5],校正年龄、性别、体重指数(BMI)和胰岛素抵抗的稳态模型评估(HOMA-IR)后。
APOA1 基因的-75A(APOA1)等位基因和 ADRB3 基因的 Arg64(ADRB3)等位基因联合增加了西班牙南部人群患 DM2 的风险。